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Abstract 
 
The human cerebral cortex is characteristically large and folded, which can be majorly attributed to the high number and 
variety of neural progenitors during embryonic development. Radial glial cells are essential neural progenitors during 
neurogenesis. In addition to giving rise to new cell types, they also provide scaffold for migrating newborn neurons. Radial glia 
are known to portray peculiar characteristics in their cell division process, including unique migratory behavior as well as 
specifically regulated cleavage furrow orientation. While these processes of radial glial division have been studied extensively, 
the underlying molecular mechanisms are still largely unknown. 
 
ABBA (actin-bundling protein with BAIAP2 homology) and NEDD9 (neural precursor cell expressed, developmentally 
downregulated 9) are proteins, which are both known to be expressed in certain radial glia progenitors during embryonic 
development, while they are mainly absent in neurons. ABBA has a defined role of regulating plasma membrane deformation 
and actin polymerization in radial glia, while NEDD9 expression levels are a known factor in the correct progression from 
mitosis to cytokinesis. An interaction between ABBA and NEDD9 has previously been identified in a yeast two-hybrid screen 
done for the embryonic mouse brain. 
 
The aim of this thesis was to validate the interaction between ABBA and NEDD9 biochemically. First, their interaction was 
evaluated by doing co-immunoprecipitation assays on the endogenous proteins from C6 cells. The second approach was to 
test, whether their interaction is directly mediated by the N-terminal SH3-domain of NEDD9 and the proline-rich C-terminal 
portion of ABBA. This was done by doing biochemical binding assays using purified proteins and domains of interest. While co-
immunoprecipitation of the two proteins gave results indicating an interaction, I could show that there is no direct binding 
between NEDD9 SH3-domain and ABBA, suggesting that the interaction might require other domains or be indirect. Together, 
these results provide valuable information that will help characterize what roles of ABBA and NEDD9 play in cortical 
development and beyond. 
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Tiivistelmä 
 
Ihmisen aivokuoren merkittäviä ominaisuuksia ovat sen suuri koko ja poimuttuneisuus. Nämä piirteet ovat laajalti alkiovaiheen 
kehityksen aikaisten hermokantasolujen korkean määrän sekä monimuotoisuuden ansiota. Radiaaligliasolut ovat erityisen 
suuressa roolissa alkion neurogeneesin aikana, sillä ne tuottavat useita eri solutyyppejä sekä toimivat mekaanisena tukena 
vastasyntyneille hermosoluille, jotka vaeltavat aivokuoren kehityksen aikana kohti lopullista sijaintiaan. Näille soluille 
tyypillisiä ominaispiirteitä ovat niiden jakautumiseen liittyvät ainutlaatuiset prosessit, kuten sooman migraatio solusyklin eri 
vaiheiden aikana sekä jakautumistason tarkka säätely. Vaikka näiden solujen jakautumisprosesseja on tutkittu melko laajalti, 
niiden taustalla vaikuttavat molekyylitason mekanismit ovat vielä suurelta osin tuntemattomia. 
 
ABBA ja NEDD9 ovat proteiineja, joiden on todettu esiintyvän radiaaligliasoluissa alkionkehityksen aikana. ABBA toimii 
säätelijänä solukalvon dynaamisissa muutoksissa sekä aktiinin polymerisaatiossa radiaaligliasoluissa, kun taas NEDD9-
ekspressiotasoilla on osoitettu olevan suora vaikutus solujen kykyyn edetä mitoosista sytokineesiin. ABBA- ja NEDD9-
proteiinien välillä on aiemmin todettu vuorovaikutus Y2H (yeast two-hybrid) -seulonnassa. 
 
Tämän pro gradu -tutkielman tavoitteena oli vahvistaa ABBA- ja NEDD9-proteiinien välinen vuorovaikutus biokemiallisesti. 
Ensin niiden vuorovaikutusta arvioitiin ko-immunopresipitaatiolla, joissa käytettiin C6-glioomasolujen endogeenisia 
proteiineja. Toinen lähestymistapa oli testata, onko näiden proteiinien välillä kyseessä välitön interaktio NEDD9:n N-
terminaalisen SH3-domeenin sekä ABBA:n proliinirikkaan C-terminaalisen osan välillä. Tämä hypoteesi testattiin käyttämällä 
puhdistettuja proteiineja sekä domeeneja biokemiallisissa sitoutumisanalyyseissä. Vaikka ko-immunopresipitaatio-
analyyseissä ilmeni selkeä vuorovaikutus, kykenin osoittamaan, ettei NEDD9 SH3-domeenin ja ABBA:n välillä ole suoraa 
sitoutumista. Tämä viittaa siihen, että vuorovaikutus voi vaatia muita domeeneja tai olla epäsuora. Nämä tulokset tarjoavat 
uutta tietoa, joka auttaa karakterisoimaan ABBA:n ja NEDD9:n biologista merkityksistä aivokuoren kehityksessä sekä muissa 
konteksteissa. 
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Abbreviations 
 
ABBA Actin-bundling protein with BAIAP2 homology 
BAR Bin-Amphiphysin-Rvs 
CAS Crk-associated substrate-related 
IPC Intermediate progenitor cell 
KD Equilibrium dissociation constant 
MCD Malformation of cortical development 
msfGFP Monomeric superfolder green fluorescent protein 
MST MicroScale Thermophoresis 
NEDD9 Neural precursor cell expressed, developmentally downregulated 9 
NTA Nitrilotriacetic acid 
oRGC Outer radial glial cell 
oSVZ Outer subventricular zone 
RGC Radial glial cell 
SPR Surface plasmon resonance 
SH3 Src Homology 3 domain 
vRGC Ventricular radial glial cell 
WH2 WASP homology 2 domain 
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1. Introduction 
 
1.1. Cortical development and radial glial cells 
 
The expanded size and folded surface area of the human neocortex enables more advanced 
cognitive activity compared to other mammalian species. This characteristic of the human brain 
can be attributed to the evolutionary increase in the number and proliferative potential of neural 
progenitors during embryonic development (Borrell, 2019; Lui et al., 2011). A specific type of 
neural progenitors known as radial glial cells (RGCs) are responsible for two main functions during 
cortical development: giving rise to new cells and guiding the migration of newborn neurons 
through scaffolding (Chou et al., 2018). The different functions of RGCs depend on their unique 
structure and apico-basolateral polarity. RGCs form a particular type of polarized, pseudostratified 
epithelium which lines the ventricular wall during cortical development (Chou et al., 2018). 
 
RGCs are classified into ventricular RGCs (vRGCs; also known as apical RGCs) and outer RGCs 
(oRGCs; also known as basal RGCs). Neurogenesis begins as neuroepithelial cells, which mainly 
divide symmetrically, transition into RGCs, which can undergo asymmetric divisions in addition to 
self-renewal (Chou et al., 2018). vRGCs emerge first, and during early development they populate 
the ventricular zone through symmetric divisions to increase the initial vRGC progenitor 
population (LaMonica et al., 2013; Ostrem et al., 2016; Figure 1). vRGCs are the primary cortical 
progenitors and produce neurons through direct neurogenesis by dividing asymmetrically (Borrell, 
2019). vRGC divisions can either be vertical (cleavage furrow is perpendicular to the ventricular 
surface), horizontal (cleavage furrow is parallel to the ventricular surface) or oblique (LaMonica et 
al., 2013). Vertical vRGC divisions can either be a source of self-renewal or give rise to 
intermediate progenitor cells (IPCs), while later in neurogenesis horizontal vRGC divisions produce 
oRGCs (LaMonica et al., 2013). oRGCs are also born from vRGCs that delaminate from the 
ventricular surface (Ostrem et al., 2016). Both IPCs and oRGCs can also produce cortical neurons 
through a process known as indirect neurogenesis, which enables a higher level of cortical 
expansion (Borrell, 2019; Hansen et al., 2010). 
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Figure 1. Different types of radial glial cells throughout cortical development. Ventricular radial glia (vRG) 
are the first cell type to emerge at the beginning of neurogenesis, and they mainly divide symmetrically for 
self-renewal during early cortical development. Outer radial glia (oRG), intermediate progenitor cells (IPCs) 
and neurons emerge from asymmetric divisions later, as neurogenesis proceeds. The migration of newborn 
neurons towards the cortical plate is guided with a scaffold provided by the basal processes of radial glia. 
The image is modified from Ostrem et al., 2016. 
 
The soma of a vRGC is located close to the ventricular surface and it has contact with both the 
ventricular surface through its apical domain, as well as the pial surface through an extensive 
membrane protrusion known as the basal fibre (Chou et al., 2017; Ostrem et al., 2016; Figure 1). 
Inheritance of these apical and basal processes has a significant role in cell fate determination of 
vRGC divisions (Chou et al., 2017; LaMonica et al., 2013). oRGCs have a basal fibre similar to 
vRGCs, but they lack contact with the ventricular surface (Ostrem et al., 2016). The basal fibres of 
RGCs extend across the developing cortical layers towards the pial surface, and provide a scaffold 
for neuronal migration (Chou et al., 2017). After neurons and IPCs are born from vRGCs at the 
ventricular surface, they must delaminate and migrate towards the cortical plate and their final 
locations (Borrell, 2019; Figure 1). The long basal processes of vRGCs could also provide a 
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mechanism for the regulation of neural progenitor proliferation by transporting certain mRNAs to 
the pial surface for local translation (Borrell, 2019). 
 
While oRGCs share some similarities with vRGCs in their molecular components and morphology, 
they have unique characteristics and roles in cortical development. The majority of oRGC divisions 
lead to self-renewal through horizontal division, while only a small portion of divisions generate 
IPCs (LaMonica et al., 2013; Ostrem et al., 2016). This characteristic could be explained by oRGCs 
being transit-amplifying cells, which means that they undergo many rounds of self-renewal before 
differentiation to IPCs (Ostrem et al., 2016). oRGCs populate the outer subventricular zone (oSVZ) 
during development and their divisions lead to the expansion of the oSVZ. This attributes to upper 
layer neurogenesis and it is seen as a significant process in primate neocortex development (Lui et 
al., 2011; Ostrem et al., 2016). A higher proliferation rate of both IPCs and oRGCs has been linked 
to species with a large and folded cortex (Borrell, 2019). 
 
Both vRGCs and oRGCs undergo unique migratory behaviors throughout their cell cycles. vRGCs go 
through a process known as interkinetic nuclear migration, where their nuclei migrate away from 
the ventricular surface along the basal fibre after mitosis (Chou et al., 2017). The nuclei then 
migrate back before the start of a new cell cycle. oRGCs undergo a similar process known as 
mitotic somal translocation, where their soma moves towards the cortical plate before cell 
division (Ostrem et al., 2016). Although these processes seem very similar, they appear to have 
distinct underlying molecular mechanisms (Ostrem et al., 2014). Mitotic somal translocation of 
oRGCs likely contributes to more extensive transit amplification within the oSVZ (Hansen et al., 
2010). It may also be a target in some cortical malformations (Ostrem et al., 2014). 
 
At the end of neurogenesis RGCs begin to give rise to oligodendroglial lineage progenitors (Chou et 
al., 2017). By the time of birth distinct subpopulations of RGCs have shifted to producing 
ependymal cells while others have transformed into ventricular-subventricular zone type B1 cells 
(Beattie and Hippenmeyer, 2017). Type B1 cells are the prominent stem cell progenitors during 
adult neurogenesis (Beattie and Hippenmeyer, 2017). After birth most RGCs have transitioned into 
astrocytes and adult neural stem cells (Chou et al., 2017). Although RGCs seem to mostly 
disappear after birth, it has been found that radial glia fibres in neonatal mice provide scaffold for 
the migration of neuroblasts toward the injured area of the cortex (Jinnou et al., 2018). 
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Defects in cortical developmental processes can lead to different types of malformations of the 
cerebral cortex. Malformations of cortical development (MCDs) can be classified into subgroups 
based on the cellular mechanisms underlying the malformation, and how early in development 
the process is disrupted. For example, microcephalies and overgrowth disorders are classified into 
a group of malformations that follow abnormal cell proliferation or apoptosis (Desikan and 
Barkovich, 2016). Other subgroups of these disorders are malformations following abnormal cell 
migration (Group II) and malformations following abnormal postmigrational development (Group 
III). Defects in RGC functions are often involved in these underlying mechanisms (Desikan and 
Barkovich, 2016). MCDs commonly cause neurodevelopmental delay and drug-resistant early-
onset epilepsy (Reghunath and Ghasi, 2020). Understanding and investigating the molecular 
mechanisms involved in cortical development provides valuable insight for these disorders as well.  
 
1.2. ABBA 
 
ABBA (actin-bundling protein with BAIAP2 homology) was initially identified as a member of the 
IRSp53-MIM protein family (Saarikangas et al., 2008), which are classified as members of the BAR 
(Bin, Amphiphysin, Rvs) domain superfamily of proteins (Stanishneva-Konovalova et al., 2016; 
Zhao et al., 2011). Saarikangas and others (2008) discovered that ABBA is abundant in radial glial 
cells during embryonic development, while it is absent in embryonic neurons. In radial-glia-like C6-
R cells endogenous ABBA is enriched at the interface between the cortical actin cytoskeleton and 
the plasma membrane, and it regulates plasma membrane deformation and actin polymerization 
during protrusive events in these cells (Saarikangas et al., 2008). 
 
While ABBA has not been extensively studied outside the context of radial glial cells, it has been 
shown that ectopic expression of ABBA induces membrane ruffling and cell spreading in mouse 
fibroblasts, which is likely mediated by an interaction between ABBA and Rac1 (Zeng et al., 2013; 
Zheng et al., 2010). Additionally, Chatzi and others (2019) recently found that ABBA expression 
was highly induced in activated hippocampal dentate granule cells after a single period of short-
term exercise in adult mice. They hypothesized that ABBA might be involved in the induction and 
rearrangement of synapses in postsynaptic dendrites (Chatzi et al., 2019). 
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Members of the BAR domain family function as regulators of membrane rearrangements in 
eukaryotes. They are able to generate and detect local membrane curvatures, as well as recruit 
other cytosolic proteins to specific cell sites and affect actin dynamics directly or indirectly 
(Stanishneva-Konovalova et al., 2016). In general, BAR domains bind through their positively 
charged amino acids to negatively charged lipids in membranes (Stanishneva-Konovalova et al., 
2016). BAR domains are divided into subgroups based on their phylogenetic and structural 
characteristics: BAR/N-BAR, F-BAR, and I-BAR groups. Even within these subfamilies, there are 
distinctive differences between domain functions (Saarikangas et al., 2009). 
 
ABBA is specifically a part of the I-BAR (Inverse BAR) group. While classical and F-BAR domains 
induce membrane invaginations (positive membrane curvature), I-BAR domains induce membrane 
protrusions to the opposite direction (negative membrane curvature) (Zhao et al., 2011). This is 
due to I-BAR domains binding specifically to the inner surface of membrane tubules (Saarikangas 
et al., 2009) as well as their geometry being convex- rather than concave-shaped like other BAR 
domains (Zhao et al., 2011). Proteins of the I-BAR group can be further divided into the MIM-like 
subset (including ABBA and MIM) and the IRSp53 (insulin receptor tyrosine kinase substrate p53) 
subset (including IRSp53, IRTKS and FLJ22582). ABBA and MIM share a very similar domain 
structure (Stanishneva-Konovalova et al., 2016; Zhao et al., 2011). 
 
In addition to its N-terminal I-BAR domain, ABBA also has a serine-rich region, three proline-rich 
regions, a leucine zipper motif and a C-terminal WASP (Wiscott-Aldrich Syndrome Protein) 
Homology 2 domain (WH2) (Figure 2). The WH2 domain of ABBA binds ATP-actin monomers with a 
high affinity (Saarikangas et al., 2008). 
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Figure 2. Domain structure of ABBA; I-BAR = Inverse BAR domain; PP = polyproline motif; PtdIns(4,5)P2 = 
phosphatidylinositol-4,5-biphosphate; WH2 = WASP (Wiscott-Aldrich Syndrome Protein) Homology 2 
domain. 
 
1.3. NEDD9 
 
NEDD9 (neural precursor cell expressed, developmentally downregulated 9) was identified by 
Kumar and others (1992) as a gene that was highly expressed in the embryonic mouse brain and 
developmentally downregulated. It is also known as the Human enhancer of filamentation 1 
(HEF1) or Crk-associated substrate-related protein lymphocyte type (Cas-L) (Zhang and Wu, 2015). 
NEDD9 has been shown to be expressed in certain radial glia progenitors during embryonic 
development, while it is absent in neuronally committed cells (Aquino et al., 2008). In 2009, 
Aquino and others demonstrated a role for NEDD9 in neural crest cell migration. Vogel and others 
(2010) identified NEDD9 as an important downstream signaling element in Tgfβ-induced neuronal 
differentiation in cortical and hippocampal mouse progenitors, suggesting it also having a role in 
cell fate regulation. 
 
Although NEDD9 expression seems to be limited in the adult brain, Sasaki and others (2005) found 
that it was re-upregulated in the hippocampal and cortical neurons of rats after transient global 
ischemia. Additionally, Knutson and others (2015) demonstrated that NEDD9 is expressed in the 
cerebral cortex and hippocampus of adult mice, and it could possibly have a role dendritic spine 
maintenance. 
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NEDD9 is a member of the Crk-associated substrates (CAS) family of proteins, which also includes 
p130Cas and Efs/Sin. CAS proteins are involved in a variety of major cellular processes, including 
cell cycle, apoptosis, migration and proliferation (Tikhmyanova et al., 2010; Zhang and Wu, 2015). 
In general, CAS proteins function as scaffolds for a large number of different partners, and 
therefore intermediate various signaling pathways. While other CAS family members appear to be 
expressed in most cell and tissue types, NEDD9 expression varies notably (Pugacheva and Golemis, 
2006; Tikhmyanova et al., 2010). CAS proteins are associated with focal adhesions, where they 
localize during interphase (Pugacheva and Golemis, 2006). 
 
CAS proteins share a conserved structure containing four major domains (Tikhmyanova et al., 
2010; Figure 3). In NEDD9 the amino-terminal Src homology 3 (SH3) domain is encoded by amino 
acids 10-65 (Zhang and Wu, 2015). The SH3-domain is known to mediate binding with polyproline 
motifs (Kurochkina and Guha, 2013; Ohba et al., 1998). The substrate domain, encoded by amino 
acids 90-350, contains YxxP motifs which act as binding sites for SH2 domains. Amino acids 350-
650 contain a serine rich region, which forms a four-helix bundle and likely has a protein binding 
function. Finally, the carboxy-terminus of NEDD9 is highly conserved in all CAS proteins and binds 
to proteins with helix-loop-helix domains (Tikhmyanova et al., 2010; Zhang and Wu, 2015). The C-
terminus of NEDD9 allows both homodimerization and heterodimerization (Tikhmyanova et al., 
2010). 
 
Figure 3. Domain structure of NEDD9 and significant known functions of each domain; SH3 = Src 
Homology 3 domain 
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Similarly to all CAS family proteins, NEDD9 expression is regulated mainly through phosphorylation 
and proteolytic degradation (Tikhmyanova et al., 2010; Zhang and Wu, 2015). Levels of NEDD9 
expression are regulated depending on the cell cycle. NEDD9 expression is highest during the G2-
phase and mitosis, and lowest during G1-phase (Pugacheva and Golemis, 2005). At the G2-phase 
NEDD9 localizes at the centrosome, then migrates along the mitotic spindle as mitosis progresses, 
and finally by cytokinesis it is localized and degraded at the midbody (Pugacheva and Golemis, 
2005). Dadke and others (2006) showed that abnormal levels of NEDD9 expression cause defects 
in cell cycle progression. They found that while NEDD9 overexpression inhibits cells from 
progressing through cytokinesis, its depletion results in defects earlier during mitosis. This can be 
explained by the regulation of RhoA by NEDD9, since RhoA inactivation is needed for cytokinesis 
(Dadke et al., 2006). 
 
NEDD9 and the other CAS proteins have been extensively studied in the context of their role in 
cancer metastasis (Tikhmyanova et al., 2010). Altered NEDD9 expression levels have been 
identified as a significant contributor for tumor aggressiveness, metastatic potential and 
resistance to treatment in many different types of cancer (Shagisultanova et al., 2015). Thus, 
NEDD9 is regarded as a possible target for cancer therapy. 
 
1.4. Motives for investigating the interaction of ABBA and NEDD9 
 
An interaction between ABBA and NEDD9 has previously been identified in a yeast two-hybrid 
screen, where full length mouse ABBA-1 (amino acids 1-715) was used as a bait, and interacting 
partners were screened from a mouse embryo brain prey library (Hybrigenics). According to the 
Hybrigenics statistical confidence score, known as the Predicted Biological Score (PBS), the 
interaction between ABBA and NEDD9 was ranked a level C, which means there is good confidence 
in the interaction based on local and global technical parameters. The interaction was mapped to 
the N-terminal region of NEDD9, which contains the SH3-domain (Figure 3). This domain is 
generally known for interacting with proline rich regions. ABBA contains several putative proline 
rich regions of unknown function (Saarikangas et al. 2008; Figure 2). So far, one missense patient 
mutation resulting in change of amino acid 597 from threonine to methionine has been published 
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and linked to a brain dysfunction (Alazami et al., 2015). Interestingly, this mutation is situated in 
one of the proline-rich regions of the human ABBA. 
 
The biological roles of ABBA and NEDD9 in the context of brain development are not well known, 
but at the time of starting this thesis, data available at the International Mouse Phenotyping 
Consortium website indicated that ABBA knockout mice display decreased primary motor cortex 
size. Different types of malformations of cortical development are a characteristic phenotype of 
radial glial dysfunction (Desikan and Barkovich, 2016). Therefore, since both ABBA and NEDD9 are 
strongly expressed in radial glial cells (Aquino et al., 2008; Saarikangas et al., 2008), I hypothesized 
that these proteins might interact in these progenitor cells and regulate important aspects of brain 
development . 
 
2. Aims 
 
From these data we hypothesized that ABBA and NEDD9 interact physically in radial glial cells and 
are important for proper cortical development. The aim of my thesis was to try to validate the 
interaction between ABBA and NEDD9 biochemically. First, I wanted to validate their interaction 
by doing co-immunoprecipitation assays on the endogenous proteins from C6 glioma cells. The 
second aim was to test whether there is a direct interaction between the SH3-domain of NEDD9 
and ABBA. I investigated this by doing biochemical binding assays using purified proteins and 
domains of interest.   
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3. Materials and methods 
 
3.1. Cell culture maintenance and cell lysis 
 
The C6 glioma cell line was maintained in Dulbecco’s modified eagle’s medium (DMEM; pH 7,4) 
supplemented with 10 % fetal bovine serum (Gibco) and 1 % (50 units/ml) penicillin streptomycin 
(Gibco). The cells were grown in a ThermoForma Steri Cycle CO2 incubator at +37 °C with 5 % CO2. 
 
The cells were lysed at a 100 % confluency using a lysis buffer containing: 20 mM Tris-HCl (pH 8.0), 
137 mM NaCl, 10 % glycerol, 1 % Triton X-100, 2 mM EDTA and PBS added until final volume. 
Protease inhibitors were added to the lysis buffer immediately before use: 50 μg/ml PMSF (Roche) 
and cOmplete Mini EDTA-free Protease Inhibitor Cocktail (Roche) tablets (1 tablet/10 ml of lysis 
buffer). Before lysis the cells were placed on ice and washed with cold PBS. Lysis buffer was added 
on the cells (1 ml per 100 mm dish) and the cell suspension was collected.  The cell suspension was 
incubated for 30 min at +4 °C in agitation and then centrifuged (20 min, 12000 rpm, +4 °C). 
Cleared C6 lysate (supernatant) was collected and the pellet discarded. 
 
Protein concentrations of the cell lysates were determined according to the manufacturer’s 
instructions with the Pierce BCA Protein Assay Kit (Thermo Scientific). C6 cell lysates for co-
immunoprecipitation experiments were frozen with liquid nitrogen and stored in -70 °C. 
 
3.2. Co-Immunoprecipitation and Western blot analysis 
 
For the co-immunoprecipitation of endogenous ABBA and NEDD9, ABBA was pulled down from 
the C6 cell lysate with anti-ABBA primary antibody and Pierce Protein A/G Magnetic Beads 
(Thermo Scientific). The pulled down sample was then eluted from the beads and analyzed with 
Western blot to see if NEDD9 had been indirectly captured with ABBA. The primary and secondary 
antibodies used in the experiments are presented in Table 1. 
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Table 1. Antibodies used in co-immunoprecipitation and Western blot experiments 
Type Name Class Manufacturer or source 
Primary Mouse anti-HEF1 Monoclonal abcam 
Primary Rabbit anti-ABBA Polyclonal Generated by Saarikangas et 
al. (2008) 
Secondary Rabbit anti-mouse IgG 
(HRP-conjugated) 
Polyclonal Invitrogen 
Secondary Goat anti-rabbit IgG 
(HRP-conjugated) 
Recombinant polyclonal Invitrogen 
 
 
The antigen sample (C6 cell lysate) containing ~1000 µg of protein and 20 µl of anti-ABBA primary 
antibody were combined and incubated overnight (O/N) in +4 °C with mixing. Before use, 25 µl 
(0,25 mg) of magnetic beads were washed with a wash buffer containing: TBS and 0,05 % Tween-
20 (Sigma). For every wash step the beads were gently mixed and collected with a magnetic stand. 
The antigen-antibody mixture was combined with the pre-washed beads and incubated at room 
temperature (RT) for 1 hour with mixing. The beads were collected and the flow-through was 
saved for later analysis. Pre-washed magnetic beads combined with the antigen sample without 
antibody were used as a negative control. 
 
The beads were washed 3 x with the wash buffer and 1 x with purified water before elution. 
Elution was either done by A) adding 30 µl of SDS-PAGE reducing sample buffer to the tube and 
incubating the beads at RT for 10 min with mixing before separation, or B) doing a low pH elution 
by adding 50 µl of elution buffer (0,1 M glycine; pH 2,0), incubating the beads at RT for 10 min 
with mixing, and finally adding 7,5 µl of neutralization buffer (1 M Tris; pH 7,5-9) before 
magnetically separating the beads. The differences resulting from these two methods are shown 
and discussed further in Results (Chapter 4.1.). 
 
Original C6 lysate, flow-through sample, negative control and eluted sample were analyzed with 
Western blotting. Samples were heat shocked for 5 min at +100 °C and cooled down on ice before 
loading on a 4-20 % Mini-PROTEAN TGX Gel (Bio-Rad). The gels were run at 150 V until the front 
reached the marked line. Blotting was done using the Trans-Blot Turbo Mini PVDF Transfer Packs 
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and Transfer System (Bio-Rad). Blotted membranes were blocked with 5% milk solution in TBST 
(TBS with 0,1 % Tween-20) for 1 hour on a rocking platform in RT. The membrane was then 
incubated O/N in +4 °C on a rocking platform with a 1:1000 dilution of anti-NEDD9 primary 
antibody in 5 % milk in TBST. The membrane was then rinsed 1 x and washed 3 x 5 min with TBST. 
Membrane was incubated in 1:1000 dilution of secondary antibody in 5% milk TBST for 1h on a 
rocking platform in RT, rinsed 1 x and washed 2 x 5 min with TBST. HRP detection of secondary 
antibodies was done according to the manufacturer’s instructions with the Pierce ECL Western 
Blotting Substrate (Thermo Scientific). Blotted membranes were imaged with UVP. 
 
3.3. Plasmid construction 
The ABBA C-terminal fragment corresponding to residues 274-715 was previously cloned into the 
pHAT1 vector (Saarikangas et al. 2008) and obtained from the Lappalainen group.  
A DNA-fragment corresponding to the SH3-domain of NEDD9 was amplified by PCR and cloned 
into the pBAT4-msfGFP-HsTpm2 vector (also obtained from the Lappalainen group). All primers 
used in plasmid constructions are listed in Table 2. The vector was linearized using primers 361 
and 362, which exclude the TPM2 gene from the vector. The SH3-domain was extracted with 
primers 359 and 360 which contained overlapping regions of the vector.  
To create the negative control for the biochemical binding assays, a His-tagged msfGFP was also 
purified (without the SH3-domain). For this, the original vector was linearized with primers 361 
and 362 and the TPM2-gene was excluded. 
Finally, for cloning msfGFP-constructs with a TEV-protease site (Glu-Asn-Leu-Tyr-Phe-Gln-Ser) in 
order to remove the 6xHis affinity tag after purification, primers 436 and 437 were used to 
linearize the vector, and insert the protease site between the 6xHis-tag and msfGFP or msfGFP-
SH3. 
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Table 2. Primers used in plasmid constructions 
Primer ID and name Sequence Description 
OJS00359  
NEDD9_SH3_HR_frw 
5’- TCT CGG CAT GGA CGA 
GCT GTA CAA GGG ATC CAT 
GGC TTC TAT GGC AAG GGC 
CTT ATA TGA CAA TG -3’ 
Forward primer designed to replace Tpm2 with 
the SH3-domain of NEDD9 in vector pBAT4-
msfGFP-HsTpm2 by homologous recombination. 
Contains SH3 sequence from NEDD9 and 
overhangs of plasmid PJS0235. 
OJS00360  
NEDD9_SH3_HR_rev 
5’- CAA GCT TAT GCA TGC 
GGC CGC ATC TAG AGG GCC 
CGG ATC CTC ACA GAA GCT 
TCA CCC GGT TGC C -3’ 
Reverse primer designed to replace Tpm2 with 
the SH3-domain of NEDD9 in vector pBAT4-
msfGFP-HsTpm2 by homologous recombination. 
Contains SH3 sequence (with STOP) from NEDD9 
and overhangs of plasmid PJS0235. 
OJS00361  
pBAT4_delTPM2_frw 
5’- TGA GGA TCC GGG CCC 
TCT AGA TGC -3’ 
Forward primer for linearizing vector pBAT4-
msfGFP-HsTpm2, so that Tpm2 would be excluded 
from the sequence. Starts with STOP. 
OJS00362  
pBAT4_delTPM2_rev 
5’- AGA AGC CAT GGA TCC 
CTT GTA CAG C -3’ 
Reverse primer for linearizing vector pBAT4-
msfGFP-HsTpm2 so that Tpm2 would be excluded 
from the sequence. 
OJS00436 
pBAT4_TEV_frw 
5'-Phosphate - CAG TCA GTG 
AGC AAG GGC GAG GAG 
CTG TTC - 3' 
Forward primer for linearizing vector pBAT4-
msfGFP-HsTpm2 so that a TEV-protease site is 
inserted into the sequence in the following order: 
- 6xHis - TEV - msfGFP - 
OJS00437 
pBAT4_TEV_rev 
5'-Phosphate - GAA GTA 
CAG GTT CTC GTG ATG ATG 
ATG ATG ATG TGC CAT GGA 
TAT ATC - 3' 
Reverse primer for linearizing vector pBAT4-
msfGFP-HsTpm2 so that a TEV-protease site is 
inserted into the sequence in the following order: 
- 6xHis - TEV - msfGFP - 
 
Plasmids were purified according to the according to the manufacturer’s instructions with the 
GeneJET Plasmid Miniprep Kit (Thermo Scientific). All purified plasmids were verified with Sanger 
sequencing before further use. 
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3.4. Protein expression and purification 
 
A BL21 strain of Escherichia coli was used for high-level expression of all constructs that were then 
purified from the bacterial cells (purified constructs are listed in Table 3). 2-3 liters of inoculated 
bacterial culture supplemented with 100 µg/ml ampicillin was grown at +37 °C with shaking at 220 
rpm until an OD600-value of 0,6 was reached. Protein expression was induced by adding IPTG 
(Thermo Scientific) to the culture until a final concentration of 1 mM. The culture was then 
induced for 5 hours by growing at +37 °C with shaking (220 rpm). After induction the cells were 
harvested by centrifugation (4000 x g, 20 min). Cell pellets were stored O/N in -80 °C. 
 
The bacterial cells were lysed with a lysis buffer containing: 50 mM Tris, 200 mM NaCl, 10 mM 
imidazole; pH 7,5. Protease inhibitors were added to the lysis buffer immediately before use: 50 
μg/ml PMSF (Roche) and cOmplete Mini EDTA-free Protease Inhibitor Cocktail (Roche) tablets. 
Lysozyme (Sigma-Aldrich) was added to the lysate (1 mg/ml) and it was incubated for 30 min on 
ice. The lysate was then sonicated with the Sonifier Cell Disruptor B-30 (Branson) using 30 x 10 s 
bursts with a 50 s cooling period between each burst. The lysate was then centrifuged (10000 x g, 
30 min, +4 °C) to pellet the cellular debris. The cleared lysate (supernatant) was used for further 
purification. 
 
For every 4 ml of cleared lysate, 1 ml of Ni-NTA SUPERFLOW (Qiagen) was added. The mixture was 
incubated overnight at +4 °C on a rotary shaker. Next day, the lysate-Ni-NTA mixture was loaded 
into a column and the flow-through was collected. The column was washed 2 x with 10 ml of wash 
buffer containing: 50 mM Tris, 200 mM NaCl, 20 mM imidazole; pH 7,5. Bound protein was eluted 
with elution buffer containing: 50 mM Tris, 200 mM NaCl, 300 mM imidazole; pH 7,5. 
 
The eluted sample was concentrated to a volume of < 2 ml using Amicon Ultra-15 Centrifugal Filter 
tubes (Millipore) before gel filtration chromatography. The concentrated sample was fractioned 
with HiLoad Superdex 200 using a buffer containing: 50 mM Tris, 200 mM NaCl; pH 7,5. 
Absorbance peaks were monitored with a plotter. Fractions within the highest absorbance peaks 
were collected and analyzed with SDS-PAGE. 
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Table 3. Purified protein constructs 
Name Size (kDa) 
6xHis-ABBA 274-715 47,9 
6xHis-msfGFP-SH3 34,5 
6xHis-msfGFP (negative control) 28,2 
msfGFP-SH3 33,6 
msfGFP (negative control) 27,2 
 
 
3.5. Biochemical binding assays 
 
All biochemical binding assays were done in the Biomolecular Interactions unit at the University of 
Helsinki. The purified proteins of interest were analyzed with biochemical binding assays to 
investigate the expected physical interaction between the SH3-domain of NEDD9 and C-terminal 
ABBA (amino acids 274-715).  
 
For further analyses, a custom peptide representing amino acids 546 to 560 of ABBA (Table 4) was 
ordered from Thermo Fisher Custom Peptide Synthesis Services. The choice of this specific region 
is discussed further in Results (Chapter 4.2.). The peptide was dissolved in 50 % (v/v) DMSO/water 
at a stock concentration of 3,08 mM and stored in -80 °C. 
 
Table 4. Custom peptide representing amino acids 546-560 of ABBA 
Name Sequence Size Purity 
ABBA 546-560 PIPIRPPIVPVKTPT 1,625 kDa > 98 % 
 
 
3.5.1.  MicroScale Thermophoresis 
 
MicroScale Thermophoresis (MST) experiments were done using the Monolith NT.115 
(NanoTemper Technologies) and MO.Control software (v1.5.3; NanoTemper). In MST, one binding 
partner (target) needs to be fluorescently labeled and kept at a constant concentration, while the 
other non-fluorescent partner (ligand) has a varied concentration by serial dilution. Binding is 
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determined based on differences in thermophoretic movement of bound and unbound molecules 
within a thermal gradient. Binding induced changes are detected by changes of the fluorescent 
signal. 
 
In our analyses 6xHis-msfGFP-SH3 and 6xHis-msfGFP were used as fluorescent targets and 6xHis-
ABBA as the non-fluorescent ligand. All MST measurements were performed in Standard treated 
capillaries (NanoTemper) with 100 % excitation power, blue excitation color (465-490 nm), 40 % 
MST power and a temperature of +22,0 °C. The target concentrations were at kept at a constant 
10 nM, and ligand (ABBA) concentration ranged from 0,0167 mM to 5,08 * 10-7 mM. Raw data was 
analyzed with MO.Affinity Analysis software (v2.3; NanoTemper) to plot binding curves and 
estimate KD-values for the interactions. 
 
3.5.2.  Surface plasmon resonance 
 
Surface plasmon resonance (SPR) experiments were done using the Biacore T100 (Biacore AB). SPR 
analyses require one partner to be immobilized onto a chip surface.  The capture of histidine-
tagged proteins was done via nickel (Ni2+) chelation of NTA using a Series S Sensor Chip NTA (GE 
Healthcare). All solutions used in the experiments (listed in Table 5) were filtered sterile before 
use. 
 
Table 5. Solutions used in SPR experiments 
Solution Description 
Running buffer 50 mM Tris; 200 mM NaCl; pH 7,5 
Nickel solution 0,5 mM NiCl2 (Acros Organics) in water 
Regeneration solution 350 mM EDTA; pH 8,3 
Washing solution 3 mM EDTA 
 
Before the first analysis cycle of each run, the chip surface was conditioned with regeneration 
solution (1 min pulse). The NTA chip surface was prepared with nickel solution to saturate the NTA 
(1 min pulse). 6xHis-ABBA (274-715) was used as the histidine-tagged ligand and captured on the 
NTA chip using an optimized concentration of 1,25 µg/ml, flow rate of 10 µl/min and a contact 
time of 60 s.  
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Interaction analysis was done using the msfGFP and msfGFP-SH3 constructs purified with no His-
affinity tag (Table 3). An optimized concentration range from 500 nM to 5000 nM was used for the 
samples. The analytes were injected at a flow rate of 30 µl/min and a contact time of 180 s. 
Dissociation time of 300 s was used and all regeneration steps were done using 0,35 M EDTA. 
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4. Results 
 
4.1. Co-immunoprecipitation of endogenous proteins 
 
In order to see if endogenous ABBA and NEDD9 interact in C6 cells, co-immunoprecipitation 
experiments were done using ABBA as the primary target protein. Presence of NEDD9 (secondary 
target) was then analyzed from the final eluted samples, to see if it had been pulled down 
indirectly in the experiment, which would indicate an interaction between the two proteins. 
 
Western blot results are presented for two different optimization attempts of the co-
immunoprecipitation experiments with ABBA and NEDD9 (Figure 4). Since endogenous ABBA was 
used as the bait-protein in the pull-down assays, anti-NEDD9 bands are showcased in the results. 
Due to the high level of phosphorylation in the regulation of NEDD9 expression, the protein 
typically shows two bands at around 105,5 kDa and 115 kDa (Zhang and Wu, 2015). Both of these 
bands can be seen clearly in the original C6 cell lysate sample and the co-immunoprecipitation 
flow-through sample (which consists of everything that was not pulled down with ABBA) in both 
attempts. 
 
 
Figure 4. Western blot analysis of co-immunoprecipitation assays for NEDD9 pulldown with endogenous 
ABBA from C6 cells; C6 = original C6 cell lysate; FT = flow-through sample; NC = negative control; ES = 
eluted sample.  
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The first experiment shown (Figure 4a) lacked a negative control. However, the NEDD9 protein 
bands can be seen much clearer in the eluted sample of the first experiment, in comparison to the 
second one (Figure 4b), where a negative control was included. This could be explained by 
different elution methods used in these experiments. In the first experiment (Figure 4a), the final 
sample was eluted using SDS-PAGE reducing sample buffer, while the second experiment (Figure 
4b) was done using low pH elution. Otherwise the two experiments were done using the same 
protocol and materials (for example primary and secondary antibodies). In total, co-
immunoprecipitation involved several optimization steps (altogether seven separate attempts) 
and based on these results the SDS-PAGE elution gave the best result in preserving the interaction. 
 
Eluted samples from both experiments show a stronger signal for the lower protein band of 
NEDD9 at around 100 kDa. This indicates, that ABBA binds preferentially to the non- (or less) 
phosphorylated form of NEDD9. The higher band of 115 kDa represents the hyper-phosphorylated 
form of NEDD9, which is considered to be the active form of NEDD9 in the context of its ability to 
bind with various partners. 
 
4.2. Identification of possible SH3-domain interaction sites in the ABBA sequence 
 
Based on the previously done yeast two-hybrid screen, NEDD9 interacts with ABBA through its N-
terminal region, which contains an SH3-domain (Figure 3). Therefore, after testing the interaction 
with endogenous proteins, I wanted to investigate if the interaction of ABBA and NEDD9 is direct 
and mediated by the SH3-domain of NEDD9 and the proline-rich region of ABBA. 
 
SH3-domains are known to bind both canonical and non-canonical proline rich regions. Canonical 
SH3 binding sites usually contain a PxxP-motif with possible flanking residues, which can 
contribute towards binding. These consensus sequences are generally divided into two main 
classes: class I ligands contain the sequence RXLPPXP, while class II ligands bind in the opposite 
orientation with the sequence XPPLPXR (Kurochkina and Guha, 2013). 
 
First, both canonical and non-canonical SH3-domain binding sites were searched for within the 
proline-rich C-terminal region of ABBA. A possible canonical interaction site was identified within 
ABBA amino acids 546 to 550, based on the class II consensus (Figure 5; Kurochkina and Guha, 
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2013). A custom peptide representing these amino acids was ordered (Table 4) and used as a 
possible binding partner in MST and SPR assays with the msfGFP-constructs. 
 
 
Figure 5. Possible SH3-domain interaction site was identified in the ABBA sequence (amino acids 546-
550) based on the canonical class II consensus. A) Protein sequence alignment of mouse (Mus musculus) 
and human (Homo sapiens) ABBA. Proline-rich motifs are shown within the dashed red boxes, and the 
identified consensus sequence within the black box B) Class II consensus sequence represented in the ABBA 
sequence. The symbol ɸ (Phi) represents a hydrophobic amino acid (valine in the ABBA site) and + 
represents a positively charged amino acid (lysine in the ABBA site). PxxP is known as a minimal consensus 
target site for SH3-domain binding and it is often surrounded by specific binding enhancing residues. 
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4.3. Protein purifications  
 
In order to test the direct interaction with biochemical binding assays, protein constructs 
representing the domains of interest were purified. I decided to directly focus on purifying 
individual domains and partial constructs, as the expression and purification of large full-length 
proteins the size of ABBA and NEDD9 is typically difficult and can result in reduced yields of total 
protein that is more instable than the individual domains. Since my initial plan was to mainly use 
MicroScale Thermophoresis for binding analyses, one binding partner needed to be a fluorescently 
tagged construct. Thus, the SH3-domain of NEDD9 was purified as a part of a 6xHis-tagged 
msfGFP-construct to be used as the fluorescent partner. The C-terminal portion of ABBA was 
purified as the non-fluorescent partner, as well as the empty msfGFP-construct as a negative 
control. 
 
Samples were collected at distinct points during the protein expression and purification process of 
each construct, which were then analyzed in the end with SDS-PAGE (Figure 6). This was done in 
order to validate a successful purification, and to determine in the case of an unsuccessful 
attempt, which step in the expression or purification process had failed. Additionally, collected 
fractions from fast protein liquid chromatography (FPLC) were analyzed independently with SDS-
PAGE, to confirm that they indeed contained the purified protein of interest, before pooling the 
correct fractions into one sample. 
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Figure 6. Schematic representation of the protein purification methods. The msfGFP-construct purification 
is used as an example. Samples taken for final SDS-PAGE analysis at different steps are shown in the figure. 
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4.4. MicroScale Thermophoresis 
 
MST binding assays were first optimized for ABBA 274-715 as the ligand and msfGFP-SH3 as the 
fluorescent target. These experimental conditions were repeated for the msfGFP-target, which 
represents the empty negative control, and in theory should not show any kind of binding with C-
terminal ABBA. Surprisingly the results showed very similar quantitative binding affinity in both 
experiments (Figure 7). 
 
 
Figure 7. Results from MST binding analyses using ABBA 274-715 as a ligand, and either msfGFP-SH3 or 
msfGFP as the fluorescent target. A) Capillary scans showing fluorescent target signals in capillaries 1-16. 
B) MST-traces C) Binding curves were plotted using raw fluorescence values, due to the signal changes. 
29 
 
 
Capillary scans showed a peculiar pattern in the fluorescence signals (Figure 7a). Since the target 
concentration is kept at a constant in all 16 capillaries while the ligand (in this case ABBA) 
concentration changes, fluorescent signal should be consistent in all reactions. However, in both 
cases the highest signals seem to be induced by higher concentrations of the ligand (capillaries 1 
through 6 or 7). This was confirmed not to be caused by a pipetting error by doing several 
repetitions, and by seeing that addition of a detergent (different concentrations of Tween-20 were 
tested), the phenomenon disappears. However, the addition of detergent resulted in no binding 
being detected (data not shown). 
 
Due to these changes in fluorescence, the binding curves were plotted using raw fluorescence 
counts instead of relative fluorescence (Figure 7c). KD-values were estimated for both experiments 
and they are shown in Table 6. 
 
Table 6. Estimated KD-values from biochemical binding assays 
Assay method Partner 1 Partner 2 KD-value 
MST ABBA 274-715 msfGFP-SH3 1,472 µM 
MST ABBA 274-715 msfGFP (negative control) 0,629 µM 
SPR ABBA 274-715 msfGFP-SH3 0,905 µM 
SPR ABBA 274-715 msfGFP (negative control) 0,866 µM 
 
4.5. Surface plasmon resonance 
 
Due to MST assays giving quite inconclusive results, I wanted to check binding for the same 
purified constructs using SPR, where fluorescence is not a contributing factor in binding 
measurements.  
 
SPR binding assays were first optimized for His-tagged ABBA 274-715 as the immobilized ligand 
and msfGFP-SH3 (purified without a 6xHis-tag) as the interaction partner that passes over the 
ligand in solution. These experimental conditions were repeated with using msfGFP as the analyte. 
Sensograms show the progress of interaction at different analyte concentrations (Figures 8a and 
9a). The 1:1 binding model was assumed for ABBA and NEDD9, so interaction affinities could be 
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determined by measuring steady-state binding levels (Figures 8b and 9b). KD-values were 
estimated for both experiments and they are shown in Table 6.  
 
 
Figure 8. SPR results for binding analysis of ABBA 274-715 and msfGFP-SH3. A) Adjusted sensograms for 
different concentrations of analyte; B) Steady state affinity; RU = resonance unit 
 
 
Figure 9. SPR results for binding analysis of ABBA 274-715 and msfGFP (negative control). A) Adjusted 
sensograms for different concentrations of the analyte; B) Steady state affinity; RU = resonance unit 
 
Similarly as with the MST assays, SPR results show remarkably similar binding behavior for the 
SH3-tagged analyte and the negative control. Differences of amplitude in the sensograms and 
steady state affinity plots between the two experiments can be explained by difference in 
molecular weight caused by the SH3-domain (Table 3). 
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4.6. Biochemical binding assays with peptides 
 
As a final experiment, I wanted to test if an interaction would occur between the NEDD9 SH3-
domain and the proline-rich class II consensus motif that was identified in the ABBA sequence 
(Figure 5). Surprisingly, MST assays done with the ABBA peptide produced different results for the 
two fluorescent targets (Figure 10). While the negative control once again resulted in changes of 
the fluorescence signal and a binding curve, the assay done with msfGFP-SH3 showed seemingly 
stable fluorescent signals in the capillary scan (Figure 10a). No binding was detected for ABBA 546-
550 and msfGFP-SH3 (Figure 10c). 
 
Figure 10. Results from MST binding analyses using ABBA 546-560 peptide as the ligand, and either 
msfGFP-SH3 or msfGFP as the fluorescent target. A) Capillary scans showing fluorescent target signals in 
capillaries 1-16. B) MST-traces C) Binding curves plotted using raw fluorescence values. 
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Finally, an SPR assay was optimized and done with the proline-rich ABBA peptide (546-560) as the 
analyte, and 6xHis-msfGFP-SH3 as the ligand immobilized on the chip. Similarly as with the MST 
assay, no binding was detected for the pair (Figure 11). 
 
 
Figure 11. SPR assay results of immobilized 6xHis-msfGFP-SH3 and ABBA 546-560 peptide. A) Adjusted 
sensograms for different concentrations of the analyte; B) Steady state affinity; RU = resonance unit 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
5. Discussion 
 
ABBA and NEDD9 have both been formerly identified as enriched proteins in certain radial glial 
cells during embryonic development. Previous data have indicated an interaction between these 
two proteins, and also suggested towards their interaction being a significant factor in radial glial 
cell processes. In my thesis, I aimed to validate the interaction of ABBA and NEDD9 biochemically, 
and test if it is mediated directly by specific domains of these proteins. I started my thesis work by 
doing binding assays on endogenous proteins and based on those results moved on to biochemical 
binding assays with purified constructs representing the domains of interest. 
 
5.1. Co-immunoprecipitation of endogenous proteins 
 
Based on the results from co-immunoprecipitation of endogenous ABBA and NEDD9, it seems that 
ABBA indeed pulls down NEDD9 from C6 cells, indicating interaction between the two. 
Interestingly, ABBA seems to preferentially interact with the non-phosphorylated or less 
phosphorylated (p105) form of NEDD9, due to the lower band at around 100 kDa being more 
prominent in the ABBA-bound fraction (Figure 4), whereas hyper-phosphorylated NEDD9 (p115) is 
a clearly more abundant band in the lysate fraction.  
 
Although factors influencing the NEDD9 p105/p115 ratio in cells have not yet been broadly 
discovered, it is known that both actin cytoskeleton integrity and cell adhesion are contributing 
processes (Singh et al., 2007). The active hyper-phosphorylated form of NEDD9 is also known to 
accumulate specifically during the G2/M-phase of the cell cycle (Shagisultanova et al., 2015). 
Therefore, preferential binding of ABBA to non-phosphorylated NEDD9 indicates that their 
interaction could occur at a specific point during the cell cycle . This could also be explained by the 
fact that hyper-phosphorylated NEDD9 is the active form that binds with several other partners, 
which could prevent its interaction with ABBA. This possible role of phosphorylation in the 
regulation of NEDD9 interaction with ABBA needs to be confirmed in the future. One approach 
could be to use mutations targeting the known phosphorylation sites in NEDD9 to inhibit its 
phosphorylation or dephosphorylation in cells. If the interaction between ABBA and NEDD9 takes 
place preferentially during a specific cell cycle phase, cell synchronization and collection of cells in 
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different cell cycle stages could be considered as an approach to validate this in future pull-down 
assays with the endogenous proteins. Finally, although protease inhibitors were used throughout 
the co-immunoprecipitation protocol, it is significant to consider that the p115 form of NEDD9 is 
seen as the main target for degradation, which could possibly affect the results. 
 
Due to a limited supply of primary antibodies, the co-immunoprecipitation experiments were not 
optimized further in the scope of this thesis work. In the future, it would be important to validate 
these results with an opposite approach, by using NEDD9 as the primary target in pull-down assays 
instead of ABBA. I did not test this in my thesis work, since our primary antibody against NEDD9 
was monoclonal (Table 1), and if the interaction of ABBA and NEDD9 would cover up the epitope 
in NEDD9, our antibody would not be able to recognize it. However, based on these preliminary 
results already, it can be concluded that an interaction likely occurs between ABBA and NEDD9 in 
C6 cells. Whether this interaction is direct or mediated by other proteins as a part of a larger 
complex is not known. Thus, it would be relevant to proceed optimizing this method in order to 
confirm this. Based on the results of the two optimization attempts shown in Figure 4, a good 
approach would be to repeat the assay using the methods of the first attempt (Figure 4a) with a 
consistent negative control. 
 
5.2. Biochemical binding assays 
 
Contrary to the co-immunoprecipitation results, further biochemical binding assays did not 
confirm the physical binding of NEDD9 SH3-domain and C-terminal ABBA. The unexpected initial 
results from MST assays with C-terminal ABBA and the msfGFP-constructs led to a conclusion, that 
the fluorescence changes that resulted in what looks like binding curve (Figure 7c), are not in fact 
binding specific, since after adding detergent to the reactions this phenomenon disappears. 
However, since addition of detergent even in small concentrations resulted in no binding detected 
between C-terminal ABBA and msfGFP (data not shown), there was no option to optimize the 
assays further, with the constructs that had been purified. Due to the inconclusive results from 
MST assays, I wanted to further test the binding of the purified constructs with SPR, where 
fluorescence is not a contributing factor in the binding detection method. Surprisingly SPR results 
confirmed, that there indeed is a binding occurring between the partners, but that it is not specific 
to the SH3-domain. 
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Estimated KD-values that resulted from the different biochemical binding assays (Table 6) are all 
within a range of 0,6 - 1,5 µM. In literature, the binding affinity of SH3-domains and canonical 
proline-rich target sequences (class I and II) is estimated to be within the range of 1-200 µM (Li, 
2005). The obtained KD-values between the empty negative msfGFP-control and the SH3-domain 
containing construct are consistent in both experimental approaches. Both MST and SPR results 
show that the empty control seems to bind with a greater affinity to C-terminal ABBA, than the 
SH3-construct. This is a very surprising and unexpected finding. Non-specific binding mediated 
either by the 6x-His-affinity tag or msfGFP in the constructs used in these experiments is a 
possibility, but highly unlikely since these are commonly used tags due to them being considered 
to have minimal non-specific binding with other proteins. In an attempt to pinpoint the problem of 
seemingly non-specific binding, BSA was used as a negative ligand control (in place of C-terminal 
ABBA) in MST assays. This gave a similar result of non-specific binding as with the other constructs, 
even with a “double-negative” control (BSA + empty msfGFP; data not shown). These results, 
taken together with the SPR experiments where msfGFP-constructs lacking a 6xHis-tag were used, 
it would seem that msfGFP in itself is causing these results of unexpected binding. If these 
experiments were to be repeated in the future, different fluorescent tags should be tried in the 
MST assays. For SPR experiments, neither partner requires a fluorescent tag, so possibly the SH3-
domain (or other domains of the NEDD9 protein) could be purified solely with a 6xHis-affinity tag 
for these assays. 
 
Using the ABBA 546-560 custom peptide as an alternative partner to test binding with SH3, 
showed that the canonical class II site that was identified from the ABBA protein sequence (Figure 
5), is not binding-specific for the SH3-domain of NEDD9. It is possible that in case the interaction 
of these two proteins is indeed a direct one, it is carried out by different domains or binding sites 
than what we predicted here. There could be various other non-consensus binding sites within the 
C-terminal portion of ABBA, which cannot be predicted directly from the protein sequence. 
Saksela and Permi (2012) evaluated, that the binding affinity and selectivity mediated by these 
non-consensus SH3 binding sites could be much greater than for the known Class I and Class II 
consensus sites and that these non-canonical interactions could make up for a substantial portion 
of all SH3-domain interactions. Overall, the results from MST and SPR binding assays could not 
confirm my hypothesis that a direct interaction with ABBA is mediated by the NEDD9 SH3-domain. 
36 
 
Thus, other domains of NEDD9 or additional proteins might be involved in facilitating the potential 
interaction between these two proteins. 
 
5.3. Concluding remarks and future prospects 
 
Radial glial cells undergo mitotic divisions throughout embryonic cortical development, and their 
unique division style is a significant factor in healthy cerebral cortex formation. Specifically, their 
cleavage furrow orientation affecting daughter cell fate as well as their unique migratory 
behaviors (MST and INM) throughout the cell cycle are known characteristics for these cells. These 
processes require distinct molecular mechanisms, which are still largely unknown. Previous data 
have shown, that ABBA and NEDD9 proteins are prominent in radial glial cells during certain 
embryonic stages, and their interaction could be a key contributor in correct cortical development. 
ABBA has a known function in the regulation of plasma membrane and actin dynamics in radial 
glial like cells, while NEDD9 is extensively regulated throughout the cell cycle, to ensure that cells 
are able to progress from mitosis to cytokinesis. Together these known biological functions of 
ABBA and NEDD9 as well as findings presented here regarding their potential interaction, raise 
questions about the exact roles of these proteins in radial glial cells . Their interaction could be 
limited to a distinct phase of the cell cycle, and it will be important to conduct further interaction 
and colocalization studies in order to dissect this specific biological role in the future, as well as 
see whether its disruption leads to defects in cortical development. 
 
Although the results from this thesis work, notably from the different biochemical binding assays, 
were disappointing and did not prove the original hypothesis of direct interaction to be correct, 
they have shed new light on how this research topic could be approached in the future. One 
possibility is that the interaction of ABBA and NEDD9 is not in fact direct between the two 
proteins, but requires additional binding partners which all together form a functional complex. 
These additional factors could be identified for example by subjecting the eluates from ABBA and 
NEDD9 immunoprecipitations to mass spectrometry and trying to identify common interactors. 
However, the possibility of a direct interaction should not be dismissed, and this topic requires 
further research. The physical interaction of these proteins could possibly be studied between 
different domains, than what have been focused on in this thesis. It will also be interesting to see, 
if new patient mutations in these genes are discovered in the future in the context of cortical 
37 
 
malformations, and what kind of new information that will provide about their biological roles and 
possibly important interaction sites. 
 
Acknowledgements 
 
Firstly, I want to thank my supervisor Juha Saarikangas for accepting me to be a part of his 
talented group of scientists and giving me the opportunity of working on such an interesting thesis 
topic. I greatly appreciate him always keeping his office door open, for when advice and guidance 
was needed. A special thank you goes to our collaborators in France, Claudio Rivera and Aurelie 
Carabalona, who have given valuable insights at various stages of my thesis work and shared with 
us their own exciting findings. I would also like to thank Pekka Lappalainen and his group for 
providing me with the necessary plasmids, antibodies and other materials for my experiments. 
Additionally I want to thank Maria Aatonen from the Biomolecular Interactions unit for teaching 
me the difficult methods that were necessary to master for completing my thesis work. Last but 
not least, I am truly grateful for my wonderful fellow lab-mates, whose company and support 
during this thesis work has been beyond important. 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
References 
 
Alazami, A., Patel, N., Shamseldin, H., Anazi, S., Al-Dosari, M., Alzahrani, F., Hijazi, H., Alshammari, 
M., Aldahmesh, M., Salih, M., Faqeih, E., Alhashem, A., Bashiri, F., Al-Owain, M., Kentab, A., 
Sogaty, S., Al Tala, S., Temsah, M., Tulbah, M., Aljelaify, R., Alshahwan, S., Seidahmed, M., Alhadid, 
A., Aldhalaan, H., AlQallaf, F., Kurdi, W., Alfadhel, M., Babay, Z., Alsogheer, M., Kaya, N., Al-
Hassnan, Z., Abdel-Salam, G.H., Al-Sannaa, N., Al Mutairi, F., El Khashab, H., Bohlega, S., Jia, X., 
Nguyen, H., Hammami, R., Adly, N., Mohamed, J., Abdulwahab, F., Ibrahim, N., Naim, E., Al-
Younes, B., Meyer, B., Hashem, M., Shaheen, R., Xiong, Y., Abouelhoda, M., Aldeeri, A., Monies, D. 
& Alkuraya, F. 2015, Accelerating novel candidate gene discovery in neurogenetic disorders via 
whole-exome sequencing of prescreened multiplex consanguineous families, Cell Reports, 10(2), p. 
148-161. 
 
Aquino, J.B., Lallemend, F., Marmigère, F., Adameyko, I.I., Golemis, E.A. & Ernfors, P. 2009, The 
retinoic acid inducible Cas-family signaling protein Nedd9 regulates neural crest cell migration by 
modulating adhesion and actin dynamics, Neuroscience, 162(4), p. 1106-1119. 
 
Aquino, J.B., Marmigère, F., Lallemend, F., Lundgren, T.K., Villar, M.J., Wegner, M. & Ernfors, P. 
2008, Differential expression and dynamic changes of murine NEDD9 in progenitor cells of diverse 
tissues, Gene Expression Patterns, 8(4), p. 217-226. 
 
Beattie, R. & Hippenmeyer, S. 2017, Mechanisms of radial glia progenitor cell lineage 
progression, FEBS Letters, 591(24), p. 3993-4008. 
 
Borrell, V. 2019, Recent advances in understanding neocortical development [version 1; peer 
review: awaiting peer review], F1000Research, 8, p. 1791. 
 
Chatzi, C., Zhang, Y., Hendricks, W.D., Chen, Y., Schnell, E., Goodman, R.H. & Westbrook, G.L. 2019, 
Exercise-induced enhancement of synaptic function triggered by the inverse BAR protein, 
Mtss1L, eLife, 8, p. e45920. 
 
Chou, F., Li, R. & Wang, P. 2018, Molecular components and polarity of radial glial cells during 
cerebral cortex development, Cellular and Molecular Life Sciences, 75(6), p. 1027-1041. 
 
Dadke, D., Jarnik, M., Pugacheva, E.N., Singh, M.K. & Golemis, E.A. 2006, Deregulation of HEF1 
impairs M-phase progression by disrupting the RhoA activation cycle, Molecular Biology of the 
Cell, 17(3), p. 1204-1217. 
 
Desikan, R.S. & Barkovich, A.J. 2016, Malformations of cortical development, Annals of Neurology, 
80(6), p. 797-810. 
 
39 
 
Hansen, D.V., Lui, J.H., Parker, P.R.L. & Kriegstein, A.R. 2010, Neurogenic radial glia in the outer 
subventricular zone of human neocortex, Nature, 464(7288), p. 554-561. 
 
Jinnou, H., Sawada, M., Kawase, K., Kaneko, N., Herranz-Pérez, V., Miyamoto, T., Kawaue, T., 
Miyata, T., Tabata, Y., Akaike, T., García-Verdugo, J.M., Ajioka, I., Saitoh, S. & Sawamoto, K. 2018, 
Radial glial fibers promote neuronal migration and functional recovery after neonatal brain 
injury, Cell Stem Cell, 22(1), p. 128-137.e9. 
 
Knutson, D.C., Mitzey, A.M., Talton, L.E. & Clagett-Dame, M. 2015, Mice null for NEDD9 (HEF1) 
display extensive hippocampal dendritic spine loss and cognitive impairment, Brain 
Research, 1632, p. 141-155. 
 
Kumar, S., Tomooka, Y. & Noda, M. 1992, Identification of a set of genes with developmentally 
down-regulated expression in the mouse brain, Biochemical and Biophysical Research 
Communications, 185(3), p. 1155-1161. 
 
Kurochkina, N. & Guha, U. 2013, SH3 domains: modules of protein–protein interactions, 
Biophysical Reviews, 5(1), p. 29-39. 
 
LaMonica, B.E., Lui, J.H., Hansen, D.V. & Kriegstein, A.R. 2013, Mitotic spindle orientation predicts 
outer radial glial cell generation in human neocortex, Nature communications, 4(1), p. 1665. 
 
Li, S.S. 2005, Specificity and versatility of SH3 and other proline-recognition domains: structural 
basis and implications for cellular signal transduction, The Biochemical Journal, 390(Pt 3), p. 641-
653. 
 
Lui, J., Hansen, D. & Kriegstein, A. 2011, Development and evolution of the human 
neocortex, Cell, 146(1), p. 18-36. 
 
Ohba, T., Ishino, M., Aoto, H. & Sasaki, T. 1998, Dot Far-Western Blot analysis of relative binding 
affinities of the Src Homology 3 domains of Efs and its related proteins, Analytical Biochemistry, 
262(2), p. 185-192. 
 
Ostrem, B., Di Lullo, E. & Kriegstein, A. 2016, oRGs and mitotic somal translocation — a role in 
development and disease, Current Opinion in Neurobiology, 42, p. 61-67. 
 
Ostrem, B.L., Lui, J., Gertz, C. & Kriegstein, A. 2014, Control of outer radial glial stem cell mitosis in 
the human brain, Cell Reports, 8(3), p. 656-664. 
 
40 
 
Pugacheva, E.N. & Golemis, E.A. 2005, The focal adhesion scaffolding protein HEF1 regulates 
activation of the Aurora-A and Nek2 kinases at the centrosome, Nature Cell Biology, 7(10), p. 937-
946. 
 
Pugacheva, E.N. & Golemis, E.A. 2006, HEF1-Aurora A interactions: Points of dialog between the 
cell cycle and cell attachment signaling networks, Cell Cycle, 5(4), p. 384-391. 
 
Reghunath, A. & Ghasi, R.G. 2020, A journey through formation and malformations of the neo-
cortex, Child's Nervous System, 36(1), p. 27-38. 
 
Saarikangas, J., Hakanen, J., Mattila, P.K., Grumet, M., Salminen, M. & Lappalainen, P. 2008, ABBA 
regulates plasma-membrane and actin dynamics to promote radial glia extension, Journal of Cell 
Science, 121(9), p. 1444-1454. 
 
Saarikangas, J., Zhao, H., Pykäläinen, A., Laurinmäki, P., Mattila, P.K., Kinnunen, P.K.J., Butcher, S.J., 
& Lappalainen, P. 2009, Molecular mechanisms of membrane deformation by I-BAR domain 
proteins, Current Biology, 19(2), p. 95-107. 
 
Saksela, K. & Permi, P. 2012, SH3 domain ligand binding: What's the consensus and where's the 
specificity? FEBS Letters, 586(17), p. 2609-2614. 
 
Sasaki, T., Iwata, S., Okano, H.J., Urasaki, Y., Hamada, J., Tanaka, H., Dang, N.H., Okano, H. & 
Morimoto, C. 2005, Nedd9 Protein, a Cas-L homologue, is upregulated after transient global 
ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia, 
Stroke, 36(11), p. 2457-2462. 
 
Shagisultanova, E., Gaponova, A.V., Gabbasov, R., Nicolas, E. & Golemis, E.A. 2015, Preclinical and 
clinical studies of the NEDD9 scaffold protein in cancer and other diseases, Gene, 567(1), p. 1-11. 
 
Singh, M., Cowell, L., Seo, S., O’Neill, G. & Golemis, E. 2007, Molecular basis for HEF1/NEDD9/Cas-L 
action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle, Cell Biochemistry and 
Biophysics, 48(1), p. 54-72. 
 
Stanishneva-Konovalova, T.B., Derkacheva, N.I., Polevova, S.V. & Sokolova, O.S. 2016, The role of 
BAR domain proteins in the regulation of membrane dynamics, Acta naturae, 8(4), p. 60-69. 
 
Tikhmyanova, N., Little, J. & Golemis, E. 2010, CAS proteins in normal and pathological cell growth 
control, Cellular and Molecular Life Sciences, 67(7), p. 1025-1048. 
 
41 
 
Vogel, T., Ahrens, S., Büttner, N. & Krieglstein, K. 2010, Transforming Growth Factor β promotes 
neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: 
Identification of Nedd9 as an essential signaling component, Cerebral Cortex, 20(3), p. 661-671. 
 
Zeng, X., Luo, X., Wang, S. & Zhan, X. 2013, Fibronectin-mediated cell spreading requires ABBA-
Rac1 signaling, Journal of Cellular Biochemistry, 114, p. 773-781. 
 
Zhang, S. & Wu, L. 2015, Roles of neural precursor cell expressed, developmentally downregulated 
9 in tumor-associated cellular processes (Review), Molecular Medicine Reports, 12(5), p. 6415-
6421. 
 
Zhao, H., Pykäläinen, A. & Lappalainen, P. 2010, I-BAR domain proteins: linking actin and plasma 
membrane dynamics, Current Opinion in Cell Biology, 23(1), p. 14-21. 
 
Zheng, D., Niu, S., Yu, D., Zhan, X.H., Zeng, X., Cui, B., Chen, Y., Yoon, J., Martin, S.S., Lu, X. & Zhan, 
X. 2010, Abba promotes PDGF-mediated membrane ruffling through activation of the small 
GTPase Rac1, Biochemical and Biophysical Research Communications, 401(4), p. 527-532. 
 
